<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Epidermal growth factor (EGFR) is involved in <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, cell differentiation, proliferation and progression of many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and is an important therapy target in lung and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To determine the potential applicability of EGFR targeted therapies, EGFR status of over 800 salivary gland <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of different entities were analyzed on DNA and protein level by FISH and IHC </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: A tissue microarray was constructed from 721 <z:mp ids='MP_0002038'>carcinomas</z:mp> and 205 <z:mpath ids='MPATH_270'>adenomas</z:mpath> of the salivary gland </plain></SENT>
<SENT sid="3" pm="."><plain>EGFR expression and EGFR gene copy number was assessed by means of immunohistochemistry and fluorescence in situ hybridization (FISH) </plain></SENT>
<SENT sid="4" pm="."><plain>EGFR mutation analysis of exon 19 and 21 was performed in a subset of 107 <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Positive immunohistochemical staining (definition?) for EGFR was shown in 324 of 663 (48.9%) salivary gland <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The frequency was dependent on the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> entity and ranged from 17.9% (30 of 168 cases) positive immunostaining in <z:mp ids='MP_0000621'>acinic cell adenocarcinomas</z:mp> to 85.7% (42 of 49 cases) in <z:e sem="disease" ids="C0001429" disease_type="Neoplastic Process" abbrv="">Warthin tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>No EGFR amplification was found by FISH </plain></SENT>
<SENT sid="8" pm="."><plain>EGFR mutation analysis of Exon 19 and 21 in 107 salivary gland <z:mp ids='MP_0002038'>carcinomas</z:mp> revealed mutations in two <z:mp ids='MP_0000621'>acinic cell adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: EGFR protein expression is common in <z:e sem="disease" ids="C0036095" disease_type="Neoplastic Process" abbrv="">salivary gland tumors</z:e> but is not associated with gene amplification </plain></SENT>
<SENT sid="10" pm="."><plain>Activating mutations of EGFR are rare </plain></SENT>
<SENT sid="11" pm="."><plain>Nonetheless, selected cases of patients with salivary gland <z:mp ids='MP_0002038'>carcinomas</z:mp> might potentially benefit of anti-EGFR therapy </plain></SENT>
</text></document>